Credit Suisse analyst Erin Wright maintained a Hold rating on Diplomat Pharmacy (NYSE: DPLO) yesterday and set a price target of $28. The company’s shares closed yesterday at $19.19.
According to TipRanks.com, Wright is a 4-star analyst with an average return of 9.2% and a 66.9% success rate. Wright covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, PRA Health Sciences, and Charles River Labs.
Diplomat Pharmacy has an analyst consensus of Moderate Buy, with a price target consensus of $26.86.
Find more picks by Best Performing Analysts >>
Based on Diplomat Pharmacy’s latest earnings release for the quarter ending December 31, the company reported a quarterly net profit of $6.54 million. In comparison, last year the company had a net profit of $4.37 million.
Based on the recent corporate insider activity of 17 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Diplomat Pharmacy, Inc. engages in the provision of pharmacy services. The company was founded by Dale Hagerman and Phil Hagerman in 1975 and is headquartered in Flint, MI.
